Last reviewed · How we verify

Placebo, gonadotropins in step-up regimen — Competitive Intelligence Brief

Placebo, gonadotropins in step-up regimen (Placebo, gonadotropins in step-up regimen) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Medicine / Fertility.

marketed Gonadotropin FSH receptor, LH receptor Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Placebo, gonadotropins in step-up regimen (Placebo, gonadotropins in step-up regimen) — University of Modena and Reggio Emilia. Gonadotropins administered in a step-up regimen stimulate the ovaries to produce multiple follicles for assisted reproductive procedures.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Placebo, gonadotropins in step-up regimen TARGET Placebo, gonadotropins in step-up regimen University of Modena and Reggio Emilia marketed Gonadotropin FSH receptor, LH receptor
ovarian stimulation ovarian stimulation Ain Shams Maternity Hospital marketed Gonadotropin FSH receptor, LH receptor
r-FSH plus HP-hMG r-FSH plus HP-hMG Instituto Valenciano de Infertilidad, IVI VALENCIA marketed Gonadotropin combination FSH receptor, LH receptor
recombinant gonadotropins recombinant gonadotropins Sheba Medical Center marketed Gonadotropin FSH receptor, LH receptor
High dose gonadotropins High dose gonadotropins Weill Medical College of Cornell University marketed Gonadotropin FSH receptor, LH receptor
Orgovyx relugolix MYOVANT SCIENCES marketed Gonadotropin Releasing Hormone Receptor Antagonist [EPC] Gonadotropin-releasing hormone receptor 2020-01-01
Orilissa ELAGOLIX AbbVie marketed Gonadotropin Releasing Hormone Receptor Antagonist Gonadotropin-releasing hormone receptor 2018-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Gonadotropin class)

  1. Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
  2. Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
  3. Organon and Co · 3 drugs in this class
  4. Fundación Santiago Dexeus Font · 3 drugs in this class
  5. Merck KGaA · 2 drugs in this class
  6. Nina la Cour Freiesleben · 2 drugs in this class
  7. IVI Madrid · 2 drugs in this class
  8. Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
  9. D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
  10. Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo, gonadotropins in step-up regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-gonadotropins-in-step-up-regimen. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: